24 Horas | Showcast - Noticias 24 - Podcast
Premios Avonni: Fármaco chileno contra la obesidad y síndrome metabólico
07 Aug 2025
La obesidad y el síndrome metabólico causan 4,7 millones de muertes anuales, además de un alto costo a nivel global. THANI BIOTECHNOLOGIES desarrolló un fármaco innovador para tratar la diabetes del síndrome metabólico que reduce el peso corporal, la grasa visceral y la glicemia. Carlos Fardella, director del Centro Traslacional de Endocrinología de la Facultad de Medicina de la Universidad Católica, ganador del premio Avonni Salud 2024, habló con 24 Horas.
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
Trump $82 Million Bond Spree, Brazil Tariffs 'Too High,' More
16 Nov 2025
Bloomberg News Now
Ex-Fed Gov Resigned After Rules Violations, Trump Buys $82 Mil of Bonds, More
16 Nov 2025
Bloomberg News Now
THIS TRUMP INTERVIEW WAS INSANE!
16 Nov 2025
HasanAbi
Epstein Emails and Trump's Alleged Involvement
15 Nov 2025
Conspiracy Theories Exploring The Unseen
New Epstein Emails Directly Implicate Trump - H3 Show #211
15 Nov 2025
H3 Podcast
Trump Humiliates Himself on FOX as They Call Him Out
15 Nov 2025
IHIP News